Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2014 (2014), Article ID 583409, 11 pages
http://dx.doi.org/10.1155/2014/583409
Research Article

Immunoregulatory Effects of Bone Marrow-Derived Mesenchymal Stem Cells in the Nasal Polyp Microenvironment

1Upper Airway Research Laboratory (URL), Department of Otorhinolaryngology, Ghent University Hospital, Ghent University, 9000 Ghent, Belgium
2Department of Otolaryngology-Head and Neck Surgery, Federal University of São Paulo, Rua dos Otonis, 700 Piso Superior, Vila Clementino, 04025-002 São Paulo, SP, Brazil
3Nephrology Division, Department of Medicine, Federal University of São Paulo, 04025-002 São Paulo, SP, Brazil
4Department of Otorhinolaryngology and Ophthalmology, University of São Paulo, 05508-070 São Paulo, SP, Brazil
5Department of Immunology, Institute of Biomedical Sciences IV, University of São Paulo, 05508-070 São Paulo, SP, Brazil

Received 21 August 2013; Revised 20 December 2013; Accepted 26 December 2013; Published 13 February 2014

Academic Editor: Bruno L. Diaz

Copyright © 2014 Rogério Pezato et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Hastan, W. J. Fokkens, C. Bachert et al., “Chronic rhinosinusitis in Europe—an underestimated disease. A GA2LEN study,” Allergy, vol. 66, no. 9, pp. 1216–1223, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Pezato, M. Świerczyńska-Krępa, E. Niżankowska-Mogilnicka, L. Derycke, C. Bachert, and C. A. Pérez-Novo, “Role of imbalance of eicosanoid pathways and staphylococcal superantigens in chronic rhinosinusitis,” Allergy, vol. 67, no. 11, pp. 1347–1356, 2012. View at Google Scholar
  3. N. van Bruaene, C. A. Pérez-Novo, T. M. Basinski et al., “T-cell regulation in chronic paranasal sinus disease,” Journal of Allergy and Clinical Immunology, vol. 121, no. 6, pp. 1435–1441, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. N. Zhang, T. van Zele, C. Perez-Novo et al., “Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease,” Journal of Allergy and Clinical Immunology, vol. 122, no. 5, pp. 961–968, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. N. van Bruaene, L. Derycke, C. A. Perez-Novo et al., “TGF-β signaling and collagen deposition in chronic rhinosinusitis,” Journal of Allergy and Clinical Immunology, vol. 124, no. 2, pp. 253–259, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Balsalobre, R. Pezato, C. Perez-Novo et al., “Epithelium and stroma from nasal polyp mucosa exhibits inverse expression of TGF-β1 as compared with healthy nasal mucosa,” Journal of Otolaryngology—Head & Neck Surgery, vol. 42, no. 1, article 29, 2013. View at Publisher · View at Google Scholar
  7. J. B. Watelet, C. Bachert, C. Claeys, and P. van Cauwenberge, “Matrix metalloproteinases MMP-7, MMP-9 and their tissue inhibitor TIMP-1: expression in chronic sinusitis vs nasal polyposis,” Allergy, vol. 59, no. 1, pp. 54–60, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. Y.-M. Lee, S.-S. Kim, H.-A. Kim et al., “Eosinophil inflammation of nasal polyp tissue: relationships with matrix metalloproteinases, tissue inhibitor of metalloproteinase-1, and transforming growth factor-β1,” Journal of Korean Medical Science, vol. 18, no. 1, pp. 97–102, 2003. View at Google Scholar · View at Scopus
  9. T. Sejima, G. Holtappels, and C. Bachert, “The expression of fibrinolytic components in chronic paranasal sinus disease,” American Journal of Rhinology and Allergy, vol. 25, no. 1, pp. 1–6, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Pezato and R. L. Voegels, “Why do we not find polyps in the lungs? Bronchial mucosa as a model in the treatment of polyposis,” Medical Hypotheses, vol. 78, no. 4, pp. 468–470, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Bousquet, W. Jacquot, A. M. Vignola, C. Bachert, and P. van Cauwenberge, “Allergic rhinitis: a disease remodeling the upper airways?” Journal of Allergy and Clinical Immunology, vol. 113, no. 1, pp. 43–49, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. S. T. Holgate, J. Holloway, S. Wilson, F. Bucchieri, S. Puddicombe, and D. E. Davies, “Epithelial-mesenchymal communication in the pathogenesis of chronic asthma,” Proceedings of the American Thoracic Society, vol. 1, no. 2, pp. 93–98, 2004. View at Google Scholar · View at Scopus
  13. L.-F. Wang, C.-Y. Chien, F.-Y. Chiang, C.-Y. Chai, and C.-F. Tai, “Corelationship between matrix metalloproteinase 2 and 9 expression and severity of chronic rhinosinusitis with nasal polyposis,” American Journal of Rhinology and Allergy, vol. 26, no. 1, pp. e1–e4, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. X. Li, J. Meng, X. Qiao et al., “Expression of TGF, matrix metalloproteinases, and tissue inhibitors in Chinese chronic rhinosinusitis,” Journal of Allergy and Clinical Immunology, vol. 125, no. 5, pp. 1061–1068, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. K. le Blanc, L. Tammik, B. Sundberg, S. E. Haynesworth, and O. Ringdén, “Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex,” Scandinavian Journal of Immunology, vol. 57, no. 1, pp. 11–20, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. S. M. Devine, C. Cobbs, M. Jennings, A. Bartholomew, and R. Hoffman, “Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates,” Blood, vol. 101, no. 8, pp. 2999–3001, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. Ê. J. Bassi, D. C. de Almeida, P. M. M. Moraes-Vieira, and N. O. S. Câmara, “Exploring the role of soluble factors associated with immune regulatory properties of mesenchymal stem cells,” Stem Cell Reviews and Reports, vol. 8, no. 2, pp. 329–342, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. B. Parekkadan and J. M. Milwid, “Mesenchymal stem cells as therapeutics,” Annual Review of Biomedical Engineering, vol. 12, pp. 87–117, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. F. S. Silva, P. N. Almeida, J. V. Rettore et al., “Toward personalized cell therapies by using stem cells: seven relevant topics for safety and success in stem cell therapy,” Journal of Biomedicine and Biotechnology, vol. 2012, Article ID 758102, 12 pages, 2012. View at Publisher · View at Google Scholar
  20. K. le Blanc and O. Ringdén, “Immunomodulation by mesenchymal stem cells and clinical experience,” Journal of Internal Medicine, vol. 262, no. 5, pp. 509–525, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. A. J. Nauta and W. E. Fibbe, “Immunomodulatory properties of mesenchymal stromal cells,” Blood, vol. 110, no. 10, pp. 3499–3506, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Di Nicola, C. Carlo-Stella, M. Magni et al., “Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli,” Blood, vol. 99, no. 10, pp. 3838–3843, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. W. J. Fokkens, V. Lund, J. Mullol et al., “European position paper on rhinosinusitis and nasal polyps 2012,” Rhinology, vol. 50, supplement 23, pp. 1–298, 2012. View at Google Scholar
  24. D. P. Lennon and A. I. Caplan, “Isolation of human marrow-derived mesenchymal stem cells,” Experimental Hematology, vol. 34, no. 11, pp. 1604–1605, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. M. F. Pittenger, A. M. Mackay, S. C. Beck et al., “Multilineage potential of adult human mesenchymal stem cells,” Science, vol. 284, no. 5411, pp. 143–147, 1999. View at Publisher · View at Google Scholar · View at Scopus
  26. L. T. Galindo, T. R. Filippo, P. Semedo et al., “Mesenchymal stem cell therapy modulates the inflammatory response in experimental traumatic brain injury,” Neurology Research International, vol. 2011, Article ID 564089, 9 pages, 2011. View at Publisher · View at Google Scholar
  27. P. Semedo, C. Donizetti-Oliveira, M. Burgos-Silva et al., “Bone marrow mononuclear cells attenuate fibrosis development after severe acute kidney injury,” Laboratory Investigation, vol. 90, no. 5, pp. 685–695, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. S.-L. Chen, W.-W. Fang, F. Ye et al., “Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction,” American Journal of Cardiology, vol. 94, no. 1, pp. 92–95, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. E. M. Horwitz, P. L. Gordon, W. K. K. Koo et al., “Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 13, pp. 8932–8937, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Rojas, J. Xu, C. R. Woods et al., “Bone marrow-derived mesenchymal stem cells in repair of the injured lung,” American Journal of Respiratory Cell and Molecular Biology, vol. 33, no. 2, pp. 145–152, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Fierabracci, A. del Fattore, R. Luciano, M. Muraca, A. Teti, and M. Muraca, “Recent advances in mesenchymal stem cell immunomodulation. The role of microvisicles,” Cell Transplantation, 2013. View at Publisher · View at Google Scholar
  32. Ê. J. Bassi, P. M. Moraes-Vieira, C. S. Moreira-Sá et al., “Immune regulatory properties of allogeneic adipose-derived mesenchymal stem cells in the treatment of experimental autoimmune diabetes,” Diabetes, vol. 61, no. 10, pp. 2534–2545, 2012. View at Google Scholar
  33. F. Dai, D. Shi, W. He et al., “hCTLA4-gene modified human bone marrow-derived mesenchymal stem cells as allogeneic seed cells in bone tissue engineering,” Tissue Engineering, vol. 12, no. 9, pp. 2583–2590, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Huang, J. Guo, F. Beigi et al., “HASF is a stem cell paracrine factor that activates PKC epsilon mediated cytoprotection,” Journal of Molecular and Cellular Cardiology, vol. 66, pp. 157–164, 2014. View at Publisher · View at Google Scholar
  35. S. Tomic, J. Djokic, S. Vasilijic et al., “Immunomodulatory properties of mesenchymal stem cells derived from dental pulp and dental follicle are susceptible to activation by toll-like receptor agonists,” Stem Cells and Development, vol. 20, no. 4, pp. 695–708, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. K. English, J. M. Ryan, L. Tobin, M. J. Murphy, F. P. Barry, and B. P. Mahon, “Cell contact, prostaglandin E2 and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25Highforkhead box P3+ regulatory T cells,” Clinical and Experimental Immunology, vol. 156, no. 1, pp. 149–160, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. S. A. Patel, J. R. Meyer, S. J. Greco, K. E. Corcoran, M. Bryan, and P. Rameshwar, “Mesenchymal stem cells protect breast cancer cells through regulatory T cells: role of mesenchymal stem cell-derived TGF-β,” Journal of Immunology, vol. 184, no. 10, pp. 5885–5894, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. K. Nemeth, A. Keane-Myers, J. M. Brown et al., “Bone marrow stromal cells use TGF-β to suppress allergic responses in a mouse model of ragweed-induced asthma,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 12, pp. 5652–5657, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. Y. C. Yang, N. Zhang, K. van Crombruggen, G. H. Hu, S. L. Hong, and C. Bachert, “Transforming growth factor-beta1 in inflammatory airway disease: a key for understanding inflammation and remodeling,” Allergy, vol. 67, no. 10, pp. 1193–1202, 2012. View at Google Scholar
  40. C. A. Pérez-Novo, C. Claeys, P. van Cauwenberge, and C. Bachert, “Expression of eicosanoid receptors subtypes and eosinophilic inflammation: implication on chronic rhinosinusitis,” Respiratory Research, vol. 7, article 75, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. K. English, F. P. Barry, C. P. Field-Corbett, and B. P. Mahon, “IFN-γ and TNF-α differentially regulate immunomodulation by murine mesenchymal stem cells,” Immunology Letters, vol. 110, no. 2, pp. 91–100, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. K. Chen, D. Wang, W. T. Du et al., “Human umbilical cord mesenchymal stem cells hUC-MSCs exert immunosuppressive activities through a PGE2-dependent mechanism,” Clinical Immunology, vol. 135, no. 3, pp. 448–458, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. K. Németh, A. Leelahavanichkul, P. S. T. Yuen et al., “Bone marrow stromal cells attenuate sepsis via prostaglandin E 2-dependent reprogramming of host macrophages to increase their interleukin-10 production,” Nature Medicine, vol. 15, no. 1, pp. 42–49, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. F. Djouad, L.-M. Charbonnier, C. Bouffi et al., “Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism,” Stem Cells, vol. 25, no. 8, pp. 2025–2032, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. G. Xu, Y. Zhang, L. Zhang, G. Ren, and Y. Shi, “The role of IL-6 in inhibition of lymphocyte apoptosis by mesenchymal stem cells,” Biochemical and Biophysical Research Communications, vol. 361, no. 3, pp. 745–750, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. T. Kishimoto, “Interleukin-6: discovery of a pleiotropic cytokine,” Arthritis Research and Therapy, vol. 8, supplement 2, p. S2, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. X.-J. Liu, J.-F. Zhang, B. Sun et al., “Reciprocal effect of mesenchymal stem cell on experimental autoimmune encephalomyelitis is mediated by transforming growth factor-β and interleukin-6,” Clinical and Experimental Immunology, vol. 158, no. 1, pp. 37–44, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. L. Huang, B. Baban, B. A. Johnson III, and A. L. Mellor, “Dendritic cells, indoleamine 2,3 dioxygenase and acquired immune privilege,” International Reviews of Immunology, vol. 29, no. 2, pp. 133–155, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. T. Honkanen, A. Luukkainen, M. Lehtonen et al., “Indoleamine 2,3-dioxygenase expression is associated with chronic rhinosinusitis with nasal polyps and antrochoanal polyps,” Rhinology, vol. 49, no. 3, pp. 356–363, 2011. View at Publisher · View at Google Scholar · View at Scopus
  50. W. Ge, J. Jiang, J. Arp, W. Liu, B. Garcia, and H. Wang, “Regulatory T-cell generation and kidney allograft tolerance induced by mesenchymal stem cells associated with indoleamine 2,3-dioxygenase expression,” Transplantation, vol. 90, no. 12, pp. 1312–1320, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. S. Aggarwal and M. F. Pittenger, “Human mesenchymal stem cells modulate allogeneic immune cell responses,” Blood, vol. 105, no. 4, pp. 1815–1822, 2005. View at Publisher · View at Google Scholar · View at Scopus